Literature DB >> 4570618

The localization of the Australia antigen in the liver by immunofluorescence.

T Akeyama, T Kamada, T Koizumi, H Abe.   

Abstract

The localization of Australia antigen in the liver by the fluorescent antibody technique (direct method) has been studied. Specific fluorescence was observed in the cytoplasm of liver cells. Two distribution patterns of fluorescent-positive cells, namely, a diffuse fluorescence in the liver lobules and a spotty distribution of fluorescent-positive cells, were observed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4570618      PMCID: PMC477623          DOI: 10.1136/jcp.25.12.1071

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  The chromatographic purification of fluorescein-antibody.

Authors:  C C CURTAIN
Journal:  J Histochem Cytochem       Date:  1961-09       Impact factor: 2.479

2.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

3.  Investigations of liver biopsies for Australia antigen by immunofluorescent technique.

Authors:  J O Nielsen; P Elling
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

4.  Virus-like particles in cytoplasm of livers of Au-antigen carriers.

Authors:  O Stein; M Fainaru; Y Stein
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.

Authors:  A Nowoslawski; W J Brzosko; K Madaliński; K Krawczyński
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

6.  [Ultrastructural study of unusual cytoplasmic inclusions in viral hepatitis. Relation with Australia antigen?].

Authors:  J Scotto; J C Homberg; H Stralin; C Salmon; J Caroli
Journal:  Presse Med       Date:  1970-11-07       Impact factor: 1.228

7.  Australia antigen and hepatitis. An electron microscopic study.

Authors:  M N Ahmed; S Huang; L Spence
Journal:  Arch Pathol       Date:  1971-07

8.  Intrahepatic expression of serum hepatitis virus-associated antigens.

Authors:  T S Edgington; D J Ritt
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

9.  Studies on fluorescent antibody staining. I. Non-specific fluorescence with fluorescein-coupled sheep anti-rabbit globulins.

Authors:  G GOLDSTEIN; I S SLIZYS; M W CHASE
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

10.  The localization of Australia antigen by immunofluorescence.

Authors:  V E Coyne; I Millman; J Cerda; B J Gerstley; T London; A Sutnick; B S Blumberg
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

View more
  6 in total

1.  Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.

Authors:  J P Camilleri; C Amat; M Chousterman; J P Petite; A Duboust; A Boddaert; A Paraf
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-12-08

2.  Methods for detection of hepatitis B surface antigen in paraffin sections of liver: a guideline for their use.

Authors:  E Sumithran
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

3.  Demonstration of hepatitis B surface antigen by orcein staining in paraffin sections of cirrhotic liver.

Authors:  I Bartók; E Remenár; J Tóth
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-02-16

4.  [Investigations concerning the fixation of hepatitis B-antigen (HBAg) on peripheral lymphocytes and isolated hepatocytes in patients with inflammatory liver diseases. (author's transl)].

Authors:  W Arnold; K H Meyer zum Büschenfelde; U Hopf; C Kordbarlag
Journal:  Klin Wochenschr       Date:  1975-03-01

5.  The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients).

Authors:  W Arnold; K H Meyer zum Büschenfelde; G Hess; J Knolle
Journal:  Klin Wochenschr       Date:  1975-11-15

6.  [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

Authors:  J Knolle; M Born; G Hess; O Klinge; W Arnold; H Bitz; K H Meyer
Journal:  Klin Wochenschr       Date:  1976-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.